Joint Effect of CFH and ARMS2/HTRA1 Polymorphisms on Neovascular Age-Related Macular Degeneration in Chinese Population

Joint Effect of CFH and ARMS2/HTRA1 Polymorphisms on Neovascular Age-Related Macular Degeneration in Chinese Population

Purpose. The etiology of neovascular age-related macular degeneration (nAMD) cannot be completely explained by identified environmental risk factors or single-locus gene variants. This study was to explore the potential interactions among gene variants on nAMD in Chinese population. Methods. 43 SNP...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kai Fang, Pei Gao, Jun Tian, Xueying Qin, Wenzhen Yu, Juan Li, Qing Chen, Lvzhen Huang, Dafang Chen, Yonghua Hu, Xiaoxin Li
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2015/821918
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
by: Ilias Zampros, et al.
Published: (2012-01-01)

OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review
by: Cristian Metrangolo, et al.
Published: (2021-01-01)

Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration
by: Gábor G. Deák, et al.
Published: (2025-02-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic
by: Jan Nemcansky, et al.
Published: (2019-01-01)

Serum lipids mediate the association of per- and polyfluoroalkyl substances exposure and age-related macular degeneration.
by: Xiaodong Chen, et al.
Published: (2025-01-01)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
by: Zongyi Wang, et al.
Published: (2020-01-01)

Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
by: Francisco Rodríguez, et al.
Published: (2024-05-01)

Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study
by: Øystein Kalsnes Jørstad, et al.
Published: (2024-12-01)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
by: Selwyn M. Prea, et al.
Published: (2015-01-01)

The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration
by: Daniel Ahmed, et al.
Published: (2021-01-01)

Efficacy Comparison of Intravitreal Anti-VEGF Therapy for Three Subtypes of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Jianqing Li, et al.
Published: (2018-01-01)

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
by: Ana Catarina Pedrosa, et al.
Published: (2017-01-01)

Three-Year Outcomes of Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept under the National Health Insurance Program in Taiwan
by: Kang-Jung Lo, et al.
Published: (2020-01-01)

Mitochondrial Stress Signalling: HTRA2 and Parkinson's Disease
by: Enrico Desideri, et al.
Published: (2012-01-01)

Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration
by: Hamid Riazi-Esfahani, et al.
Published: (2025-02-01)

Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept
by: Juliana Wons, et al.
Published: (2017-01-01)

Emotional and physical experiences of people with neovascular age-related macular degeneration during the injection process in Germany: a qualitative study
by: Oliver Zeitz, et al.
Published: (2022-06-01)

The AMD-associated genetic polymorphism CFH Y402H confers vulnerability to Hydroquinone-induced stress in iPSC-RPE cells
by: Angela Armento, et al.
Published: (2025-02-01)

Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson’s Disease
by: Ya-Chao He, et al.
Published: (2017-01-01)

Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response—a scoping review
by: Nikolaos Dervenis, et al.
Published: (2024-05-01)

Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration
by: Martin Stattin, et al.
Published: (2019-01-01)

Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
by: Joachim Wachtlin, et al.
Published: (2020-01-01)

Opportunities, challenges, and difficulties in NMR-based metabolomics applied to neovascular age-related macular degeneration (nAMD) patient follow-up
by: M. Schoumacher, et al.
Published: (2025-01-01)

Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
by: Thi Ha Chau Tran, et al.
Published: (2017-01-01)

Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
by: Nozomu Hashiya, et al.
Published: (2025-01-01)

Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
by: Thi Ha Chau Tran, et al.
Published: (2018-01-01)

Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
by: Xiaobei Yin, et al.
Published: (2022-01-01)

A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept
by: Sophie Seguin-Greenstein, et al.
Published: (2016-01-01)

Mechanism of Inflammation in Age-Related Macular Degeneration
by: Francesco Parmeggiani, et al.
Published: (2012-01-01)

Self-Examination Low-Cost Full-Field Optical Coherence Tomography (SELFF-OCT) for neovascular age-related macular degeneration: a cross-sectional diagnostic accuracy study
by: Peter Koch, et al.
Published: (2022-06-01)

Age-Related Macular Degeneration: Insights into Inflammatory Genes
by: Raffaella Cascella, et al.
Published: (2014-01-01)

Future Therapies of Wet Age-Related Macular Degeneration
by: Makoto Ishikawa, et al.
Published: (2015-01-01)

Ocular Surface Temperature in Age-Related Macular Degeneration
by: Andrea Sodi, et al.
Published: (2014-01-01)

Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up
by: Simon Javidi, et al.
Published: (2020-01-01)

A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study
by: Sergio Pagliarini, et al.
Published: (2014-01-01)

Saffron therapy for the ongoing treatment of age-related macular degeneration
by: Peter J McCluskey, et al.
Published: (2024-07-01)

Peroxisome Proliferator-Activated Receptor and Age-Related Macular Degeneration
by: Chi-Chao Chan, et al.
Published: (2008-01-01)

Relationship of Retinal Vessel Caliber with Age-Related Macular Degeneration
by: Sara Toulouie, et al.
Published: (2022-01-01)

Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation
by: Bin Wu, et al.
Published: (2016-01-01)